The role of etanercept in the treatment of patients with severe rheumatoid arthritis
The article is devoted to the use of a tumor-necrosis-factor-alpha inhibitor etanercept in patients with severe rheumatoid arthritis. The author examines various aspects of therapy with genetically engineered biologic drugs (GEBD), in particular the issues of efficiency and safety, the possibility o...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Remedium Group LLC
2013-12-01
|
| Series: | Медицинский совет |
| Subjects: | |
| Online Access: | https://www.med-sovet.pro/jour/article/view/1171 |
| _version_ | 1797841609907240960 |
|---|---|
| author | N. V. Chichasova |
| author_facet | N. V. Chichasova |
| author_sort | N. V. Chichasova |
| collection | DOAJ |
| description | The article is devoted to the use of a tumor-necrosis-factor-alpha inhibitor etanercept in patients with severe rheumatoid arthritis. The author examines various aspects of therapy with genetically engineered biologic drugs (GEBD), in particular the issues of efficiency and safety, the possibility of monotherapy, antidestructive effect of the drug, etc. |
| first_indexed | 2024-04-09T16:34:04Z |
| format | Article |
| id | doaj.art-18a7fd2be312432fac4a1c0fd3cb1247 |
| institution | Directory Open Access Journal |
| issn | 2079-701X 2658-5790 |
| language | Russian |
| last_indexed | 2024-04-09T16:34:04Z |
| publishDate | 2013-12-01 |
| publisher | Remedium Group LLC |
| record_format | Article |
| series | Медицинский совет |
| spelling | doaj.art-18a7fd2be312432fac4a1c0fd3cb12472023-04-23T06:56:58ZrusRemedium Group LLCМедицинский совет2079-701X2658-57902013-12-010129710510.21518/2079-701X-2013-12-97-1051171The role of etanercept in the treatment of patients with severe rheumatoid arthritisN. V. Chichasova0Research Institute of Rheumatology named after V.A. Nasonova RAMSThe article is devoted to the use of a tumor-necrosis-factor-alpha inhibitor etanercept in patients with severe rheumatoid arthritis. The author examines various aspects of therapy with genetically engineered biologic drugs (GEBD), in particular the issues of efficiency and safety, the possibility of monotherapy, antidestructive effect of the drug, etc.https://www.med-sovet.pro/jour/article/view/1171ревматоидный артритгенно-инженерные биологические препаратыингибиторы фактора некроза опухоли альфаэтанерцептrheumatoid arthritisgenetically engineered biologic drugstumor-necrosis-factor-alpha inhibitorsetanercept |
| spellingShingle | N. V. Chichasova The role of etanercept in the treatment of patients with severe rheumatoid arthritis Медицинский совет ревматоидный артрит генно-инженерные биологические препараты ингибиторы фактора некроза опухоли альфа этанерцепт rheumatoid arthritis genetically engineered biologic drugs tumor-necrosis-factor-alpha inhibitors etanercept |
| title | The role of etanercept in the treatment of patients with severe rheumatoid arthritis |
| title_full | The role of etanercept in the treatment of patients with severe rheumatoid arthritis |
| title_fullStr | The role of etanercept in the treatment of patients with severe rheumatoid arthritis |
| title_full_unstemmed | The role of etanercept in the treatment of patients with severe rheumatoid arthritis |
| title_short | The role of etanercept in the treatment of patients with severe rheumatoid arthritis |
| title_sort | role of etanercept in the treatment of patients with severe rheumatoid arthritis |
| topic | ревматоидный артрит генно-инженерные биологические препараты ингибиторы фактора некроза опухоли альфа этанерцепт rheumatoid arthritis genetically engineered biologic drugs tumor-necrosis-factor-alpha inhibitors etanercept |
| url | https://www.med-sovet.pro/jour/article/view/1171 |
| work_keys_str_mv | AT nvchichasova theroleofetanerceptinthetreatmentofpatientswithsevererheumatoidarthritis AT nvchichasova roleofetanerceptinthetreatmentofpatientswithsevererheumatoidarthritis |